Notable Labs gathers $10 mln Series A

Notable Labs, a provider of personalized cancer treatments, has secured $10 million in Series A financing. Builders VC led the round. In conjunction with the funding, Jim Kim, a founding member and general partner of Builders VC, joined Notable’s board of directors.

7 September 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail